These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 37508288)

  • 1. Drug Utilization Evaluation and Impact of Pharmacist Interventions on Optimization of Piperacillin/Tazobactam Use: A Retrospective Analysis and Prospective Audit.
    Arain S; Khalawi F; Parakkal SA; AlHamad HS; Thorakkattil SA; Alghashmari FFJ; AlHarbi B; Bakhashwain N; Alzawad WM; AlHomoud A
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluating the appropriate use of piperacillin /tazobactam in cardiac center of a tertiary care hospital.
    Mekdad SS; AlSayed L
    J Cardiothorac Surg; 2020 May; 15(1):70. PubMed ID: 32357895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
    Youssif E; Aseeri M; Khoshhal S
    J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia.
    Alsaleh NA; Al-Omar HA; Mayet AY; Mullen AB
    Saudi Pharm J; 2020 Nov; 28(11):1492-1498. PubMed ID: 33250656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric drug utilization evaluation of cefepime and piperacillin/tazobactam.
    Prasopchoknapaporn P; Boonsathorn S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2022 Jan; 64(1):e15276. PubMed ID: 36257611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot Study: Impact of a Pharmacist-Led 48-Hour Antibiotic Time-Out on Antibiotic Utilization and Outcome Measures in a Community Teaching Hospital.
    Chikeka K; Gbadamosi K; Tran H; Chughtai I; Muhammad S; Senay M; Lam B; Ngouajio-Teguiafa L; Nonyel N; DeLaine L; McSwain C; Price D; Michaels K
    Hosp Pharm; 2023 Jun; 58(3):277-281. PubMed ID: 37216074
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the use of piperacillin/tazobactam (Tazocin) at Hamad General Hospital, Qatar: are there unjustified prescriptions?
    Khan FY; Elhiday A; Khudair IF; Yousef H; Omran AH; Alsamman SH; Elhamid M
    Infect Drug Resist; 2012; 5():17-21. PubMed ID: 22294859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
    Liu P; Ohl C; Johnson J; Williamson J; Beardsley J; Luther V
    BMC Infect Dis; 2016 Dec; 16(1):751. PubMed ID: 27955625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals.
    Anderson DJ; Watson S; Moehring RW; Komarow L; Finnemeyer M; Arias RM; Huvane J; Bova Hill C; Deckard N; Sexton DJ;
    JAMA Netw Open; 2019 Aug; 2(8):e199369. PubMed ID: 31418804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
    Yost RJ; Cappelletty DM;
    Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem.
    Raveh D; Muallem-Zilcha E; Greenberg A; Wiener-Well Y; Schlesinger Y; Yinnon AM
    QJM; 2006 Jun; 99(6):397-406. PubMed ID: 16682440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Appropriateness of Piperacillin-Tazobactam Prescription in Community-Acquired Pneumonia: A Tertiary-Center Experience.
    Almajid A; Bazroon A; Albarbari H; Al-Awami HM; AlAhmed A; Bakhurji OM; Alharbi G; Aldawood F; AlKhamis Z; Alqarni M; Alabdullah M; Almutairi R
    Cureus; 2023 Dec; 15(12):e51385. PubMed ID: 38292950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: Opportunities for antimicrobial stewardship.
    Havey TC; Hull MW; Romney MG; Leung V
    Am J Infect Control; 2015 Sep; 43(9):946-50. PubMed ID: 26159502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustaining Antimicrobial Stewardship in a High-Antibiotic Resistance Setting.
    Ng TM; Heng ST; Chua BH; Ang LW; Tan SH; Tay HL; Yap MY; Quek J; Teng CB; Young BE; Lin R; Ang B; Lee TH; Lye DC
    JAMA Netw Open; 2022 May; 5(5):e2210180. PubMed ID: 35503216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of a Pharmacist-Driven Prospective Audit with Intervention and Feedback on the Treatment of Patients with Bloodstream Infection.
    Okada N; Azuma M; Tsujinaka K; Abe A; Takahashi M; Yano Y; Sato M; Shibata T; Goda M; Ishizawa K
    Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review.
    Janowski AB; Michaels MG; Martin JM; Green MD
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):342-5. PubMed ID: 26407269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor compliance with an antibiotic directive-A call for intensified monitoring.
    Novak F; Hørlück JT; Redder JD; Denton PW; Storgaard M
    Int J Infect Dis; 2021 Mar; 104():474-478. PubMed ID: 33465487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Stewardship in Treatment of Osteoarticular Infections Based on Local Epidemiology and Bacterial Growth Times.
    Vidal P; Fourniols E; Junot H; Meloni C; Bleibtreu A; Aubry A
    Microbiol Spectr; 2022 Dec; 10(6):e0143022. PubMed ID: 36377888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
    J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.